U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H23NO5
Molecular Weight 333.3789
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of SENECIPHYLLINE

SMILES

[H][C@@]12[C@H]3CCN1CC=C2COC(=O)[C@](C)(O)C(=C)C\C(=C\C)C(=O)O3

InChI

InChIKey=FCEVNJIUIMLVML-QPSVUOIXSA-N
InChI=1S/C18H23NO5/c1-4-12-9-11(2)18(3,22)17(21)23-10-13-5-7-19-8-6-14(15(13)19)24-16(12)20/h4-5,14-15,22H,2,6-10H2,1,3H3/b12-4-/t14-,15-,18-/m1/s1

HIDE SMILES / InChI

Molecular Formula C18H23NO5
Molecular Weight 333.3789
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 1
Optical Activity UNSPECIFIED

Seneciphylline, a pyrrolizidine alkaloid, the one of the main component of Chinese medicine herb Tusanqi, which is a reason of the hepatic sinusoidal obstruction syndrome (HSOS). In addition, experiments on rats have shown that seneciphylline had adverse effects on the development and organic morphodifferentiation of embryos, thus the pregnant people exposed to Hebra may get potential risk on the fetus.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
1991 Jan-Feb
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Hepatic sinusoidal obstruction syndrome (HSOS) induced by a Chinese medicinal herb Tusanqi
seneciphylline is a part of Chinese medicinal herb Tusanqi
Route of Administration: Oral
It was evaluated the embryotoxicity of alkaloids in Senecionis Scandentis Hebra on in vitro cultured mouse embryos. Post-implantation (8.5 d) mouse embryos were isolated from their mothers, and cultured in the medium of immediately centrifuged serum (ICS) with different concentrations of seneciphylline (target concentrations were 100, 50, 25 and 12.5 μg x mL(-1)) for 48 h. Treatment with seneciphylline had adverse effects on the development and organic morphodifferentiation of embryos.
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:51:12 GMT 2023
Edited
by admin
on Fri Dec 15 19:51:12 GMT 2023
Record UNII
0ZYZ9L5454
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SENECIPHYLLINE
HSDB   MI  
Common Name English
NSC-30622
Code English
ALPHA-LONGILOBINE
Common Name English
JACODINE
Common Name English
13,19-DIDEHYDRO-12-HYDROXYSENECIONAN-11,16-DIONE
Common Name English
.ALPHA.-LONGILOBINE
Common Name English
SENECIPHYLLINE [HSDB]
Common Name English
(3Z,6R,14AR,14BR)-3-ETHYLIDENE-3,4,5,6,9,11,13,14,14A,14B-DECAHYDRO-6-HYDROXY-6-METHYL-5-METHYLENE(1,6)DIOXACYCLODODECINO(2,3,4-GH)PYRROLIZINE-2,7-DIONE
Common Name English
SENECIPHYLLINE [IARC]
Common Name English
SENECIPHYLLINE [MI]
Common Name English
Code System Code Type Description
PUBCHEM
5281750
Created by admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
PRIMARY
HSDB
5188
Created by admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
PRIMARY
EPA CompTox
DTXSID8026016
Created by admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
PRIMARY
MERCK INDEX
m9861
Created by admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
PRIMARY Merck Index
MESH
C013678
Created by admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
PRIMARY
CAS
480-81-9
Created by admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
PRIMARY
FDA UNII
0ZYZ9L5454
Created by admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
PRIMARY
NSC
30622
Created by admin on Fri Dec 15 19:51:12 GMT 2023 , Edited by admin on Fri Dec 15 19:51:12 GMT 2023
PRIMARY